<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00345852</url>
  </required_header>
  <id_info>
    <org_study_id>R01HD041149</org_study_id>
    <nct_id>NCT00345852</nct_id>
    <nct_alias>NCT00109694</nct_alias>
  </id_info>
  <brief_title>Fetoscopic Selective Laser Photocoagulation in Twin-Twin Transfusion Syndrome</brief_title>
  <official_title>A Prospective, Randomized Multicenter Trial of Amnioreduction Vs Selective Fetoscopic Laser Photocoagulation for the Treatment of Severe Twin-Twin Transfusion Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</source>
  <brief_summary>
    <textblock>
      This is a study to compare two treatments (amnioreduction vs. selective fetoscopic laser&#xD;
      photocoagulation [SFLP]) in patients with severe twin to twin transfusion syndrome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We hypothesize that treatment of the underlying chorioangiopagus by selective fetoscopic&#xD;
      laser photocoagulation will not only improve the survival of twins but will reduce the&#xD;
      incidence of neurologic, cardiac, and developmental sequelae of twin-twin transfusion&#xD;
      syndrome (TTTS). We propose to test this hypothesis by a prospective randomized multicenter&#xD;
      trial to compare serial amnioreduction with selective fetoscopic laser photocoagulation in&#xD;
      cases of severe (stage II-IV) twin-twin transfusion syndrome (TTTS). Primary Outcomes:&#xD;
      Survival of donor twin at 30 days after birth and no treatment failure; Survival of recipient&#xD;
      twin at 30 days after birth and no treatment failure; Secondary Outcomes: Survival times of&#xD;
      each twin in utero or after birth (which may be censored at 30 days after birth); Gestational&#xD;
      age at delivery; Placental insufficiency; Cardiac outcome: echocardiographic evidence of&#xD;
      cardiac compromise; Neurologic outcome: evidence of brain injury preceding birth by MRI;&#xD;
      Postnatal comorbidity&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2002</start_date>
  <completion_date>May 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival of donor twin at 30 days after birth and no treatment failure</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Survival of recipient twin at 30 days after birth and no treatment failure</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival times of each twin in utero or after birth (which may be censored at 30 days after birth)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gestational age at delivery</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Placental insufficiency</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac outcome: echocardiographic evidence of cardiac compromise</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurologic outcome: evidence of brain injury preceding birth by MRI</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postnatal comorbidity</measure>
  </secondary_outcome>
  <enrollment>150</enrollment>
  <condition>Twin to Twin Transfusion Syndrome</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fetoscopic Selective Laser Photocoagulation</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Both twins are alive&#xD;
&#xD;
          -  TTTS diagnosed prior to 22 weeks gestation&#xD;
&#xD;
          -  Monochorionic diamniotic gestation&#xD;
&#xD;
          -  Like sex twins&#xD;
&#xD;
          -  Single placental mass&#xD;
&#xD;
          -  Thin intertwin membrane&#xD;
&#xD;
          -  Oligohydramnios in donor twin (deepest vertical pocket of â‰¤ 2 cm)&#xD;
&#xD;
          -  Polyhydramnios with deepest vertical pocket of &gt; 8 cm with or without Doppler or&#xD;
             echocardiographic changes in the recipient twin (deepest vertical pocket of &gt; 6 cm if&#xD;
             previous amnioreduction)&#xD;
&#xD;
          -  Decompressed bladder in donor not seen to fill during the ultrasound examination&#xD;
             (stage II, III, or IV), unless Doppler velocimetry changes (absent end-diastolic&#xD;
             umbilical artery flow, abnormal ductus venosus waveform), and/or echocardiographic&#xD;
             changes (valvular insufficiency, ventricular hypertrophy) are already present&#xD;
&#xD;
          -  No associated structural abnormalities&#xD;
&#xD;
          -  No sonographic evidence of CNS injury at time of entry&#xD;
&#xD;
          -  No preterm labor&#xD;
&#xD;
          -  No maternal medical contraindication to anesthesia or surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Failure to meet all inclusion criteria&#xD;
&#xD;
          -  TTTS presenting after 22 weeks gestation&#xD;
&#xD;
          -  Randomization after 24 weeks gestation&#xD;
&#xD;
          -  Cervical length &lt; 2.0 cm post initial&#xD;
&#xD;
          -  Presence of cervical cerclage&#xD;
&#xD;
          -  Uterine anomaly&#xD;
&#xD;
          -  Refusal to accept randomization&#xD;
&#xD;
          -  Unable to pursue prenatal care at an approved center coordinated by one of the&#xD;
             participating institutions&#xD;
&#xD;
          -  Unable to pursue postnatal evaluation at a NICHD Neonatal Research Network Institution&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy M Crombleholme, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California-San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evanston Northwestern Healthcare</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia-Presbyterian Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Magee-Women's Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Virginia Medical School</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fetalcarecenter.org/medicine/therapies/ttts/</url>
    <description>Fetal Care Center of Cincinnati Twin-Twin Transfusion Syndrome (TTTS) webpage</description>
  </link>
  <verification_date>June 2006</verification_date>
  <study_first_submitted>June 27, 2006</study_first_submitted>
  <study_first_submitted_qc>June 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2006</study_first_posted>
  <last_update_submitted>June 28, 2007</last_update_submitted>
  <last_update_submitted_qc>June 28, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2007</last_update_posted>
  <keyword>twin to twin transfusion syndrome</keyword>
  <keyword>fetoscopic selective laser photocoagulation</keyword>
  <keyword>amnioreduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetofetal Transfusion</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

